Table 5.
Results of the multivariable logistic regression analysis for the predictors of hospital mortality and six-month mortality
| Hospital mortality | Six-month mortality | |||||||
|---|---|---|---|---|---|---|---|---|
| Model 1* | Model 2** | Model 1* | Model 2** | |||||
| Odds ratio (95% CI) | P-value | Odds ratio (95% CI) | P-value | Odds ratio (95% CI) | P-value | Odds ratio (95% CI) | P-value | |
| Age per year increment | 1.005 (0.976, 1.035) | 0.73 | 1.005 (0.977, 1.034) | 0.73 | 1.021 (1.000, 1.042) | 0.046 | 1.020 (1.000, 1.041) | 0.051 |
| Female vs. male sex | 1.584 (0.528, 4.756) | 0.41 | 1.611 (0.538, 4.827) | 0.39 | 0.900 (0.446, 1.816) | 0.77 | 0.931 (0.460, 1.881) | 0.84 |
| Obesity (BMI ≥ 30 kg/m2) vs. no obesity | 1.648 (0.643, 4.225) | 0.30 | 1.586 (0.624, 4.031) | 0.33 | 0.476 (0.235, 0.964) | 0.04 | 0.443 (0.219, 0.895) | 0.02 |
| Diabetes vs. no diabetes | 1.584 (0.528, 4.756) | 0.45 | 1.363 (0.455, 4.080) | 0.58 | 1.867 (0.844, 4.131) | 0.12 | 1.828 (0.831, 4.020) | 0.13 |
| Hypertension vs. no hypertension | 0.806 (0.246, 2.638) | 0.72 | 0.919 (0.288, 2.929) | 0.89 | 1.114 (0.469, 2.647) | 0.81 | 1.151 (0.488, 2.712) | 0.75 |
| Hyperlipidemia vs. no hyperlipidemia | 0.811 (0.283, 2.325) | 0.70 | 0.797 (0.279, 2.272) | 0.67 | 0.786 (0.386, 1.601) | 0.51 | 0.765 (0.377, 1.552) | 0.46 |
| History of myocardial infarction vs. no history | 0.609 (0.115, 3.221) | 0.56 | 0.646 (0.124, 3.355) | 0.60 | 0.383 (0.112, 1.312) | 0.13 | 0.418 (0.122, 1.435) | 0.17 |
| CKD vs. no CKD | 1.013 (0.252, 4.068) | 0.99 | 1.145 (0.293, 4.478) | 0.85 | 1.563 (0.595, 4.102) | 0.37 | 1.893 (0.720, 4.981) | 0.20 |
| Heart failure vs. no heart failure | 0.609 (0.115, 3.221) | 0.49 | 1.722 (0.402, 7.380) | 0.46 | 1.474 (0.530, 4.099) | 0.46 | 1.614 (0.579, 4.499) | 0.36 |
| COPD vs. no COPD | 0.609 (0.115, 3.221) | 0.89 | 0.964 (0.071, 13.130) | 0.98 | 0.979 (0.114, 8.420) | 0.99 | 0.843 (0.100, 7.096) | 0.88 |
| Malignancy vs. no malignancy | 1.336 (0.362, 4.930) | 0.66 | 1.340 (0.366, 4.903) | 0.66 | 1.893 (0.765, 4.679) | 0.17 | 2.018 (0.819, 4.976) | 0.13 |
| Previous VTE vs. no previous VTE | 0.000(0.000, -) | 1.0 | 0.000(0.000, -) | 1.0 | 0.393 (0.123, 1.256) | 0.12 | 0.348 (0.109, 1.109) | 0.07 |
| PE diagnosis after 48 h vs. within 48 h of admission | 1.336 (0.362, 4.930) | 0.41 | 0.636 (0.190, 2.127) | 0.46 | 1.012 (0.465, 2.201) | 0.98 | 1.011 (0.465, 2.196) | 0.98 |
| PESI per one point increment | 1.480 (0.977, 2.242) | 0.06 | 1.480 (0.985, 2.224) | 0.06 | 1.325 (0.985, 1.784) | 0.06 | 1.337 (0.996, 1.795) | 0.053 |
| Intermediate-high or high vs. low or intermediate low risk PE | 2.800 (0.999, 7.849) | 0.05 | 2.448 (0.872, 6.872) | 0.09 | 0.627 (0.284, 1.387) | 0.25 | 1.248 (0.595, 2.617) | 0.56 |
| Central vs. peripheral thrombus location | 0.392 (0.128, 1.199) | 0.10 | 0.653 (0.242, 1.762) | 0.40 | 1.598 (0.748, 3.413) | 0.23 | 1.391 (0.695, 2.783) | 0.35 |
*In model 1, central PE was defined as saddle PE or PE with thrombus in the main pulmonary artery and peripheral PE as PE with more distal thrombus
**In model 2, central PE was defined as saddle PE or PE with thrombus in the main pulmonary artery or a lobar artery and peripheral PE as PE with more distal thrombus
BMI Body mass index, CI Confidence interval, CKD Chronic kidney disease, COPD Chronic obstructive pulmonary disease, PE Pulmonary embolism, PESI Pulmonary embolism severity index, VTE Venous thromboembolism